Responsibilities of sponsors are limited in premature discontinuation of trials [15]

British Medical Journal

Volumn 323, Issue 7303, 2001, Pages 53-

  Ashcroft, R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRUISM; CLINICAL RESEARCH; CLINICAL TRIAL; FINANCIAL MANAGEMENT; HUMAN; LETTER; MEDICAL ETHICS; PRIORITY JOURNAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CLINICAL TRIALS; DRUG INDUSTRY; ETHICS, MEDICAL; HUMANS; RESEARCH SUPPORT; SOCIAL RESPONSIBILITY;

EID: 0035822312     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Premature discontinuation of clinical trial for reasons nor related to efficacy, safety or feasibility
2. Societal responsibilities of clinical trial sponsors
3. The ethics of prematurely stopping a clinical trial
4. Orphan drugs: European Union priorities for research and regulatory actions